Drugs / erythropoietin-β
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01012063 | Aug 2008 → Oct 2009 | anemia | Seoul National University Bundang Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | erythropoietin-β | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01012063 ↗ |
| Known as | Epo-β | “The 200 mg of iron sucrose diluted with 100 ml of normal saline was given intravenously over one hour and the 3000 IU of Epo-β was injected subcutaneously.” NCT01012063 ↗ |
| Route | Subcutaneous | “the 3000 IU of Epo-β was injected subcutaneously” NCT01012063 ↗ |